Skip to main content
SpringerLink
Log in

TRF2 Overexpression at the Surgical Resection Margin: A Potential Predictive Biomarker in Oral Squamous Cell Carcinoma for Recurrence

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most prevalent cancers in India with high incidence rate in eastern region due to habits of tobacco, pan and gutkha chewing habits. In majority of OSCC, the cases were presented to clinicians at later stages of the disease which leads to increased mortality. In addition presence of minimal residual disease also significantly contributed towards disease progression. Therefore, identification of potential biomarker for prognostic stratification of patients with high risk of disease recurrence and appropriate management is utmost necessary. In this study, 80 OSCC patients were included and their tumour specimen along with cut margin (CM) was collected after surgical excision. Immunohistochemistry (IHC) was performed to check expression of TRF2 in tumour and CM of OSCC patients. Statistical analysis was carried out using SPSS based on clinical and pathological records. It was observed that 27 OSCC patients developed recurrence during the period of the study (2012–2016). It was observed that, in 34 cases (42.25%) TRF2 expression was positive in tumour, while in 46 cases (57.75%), it was negative, while it was just reverse at CM, respectively. The odds of recurrence among patients having high levels of TRF2 in CM were 2.6 times higher than the odds of recurrence among patients having lower levels of TRF2 in CM. In conclusion, this study showed that TRF2 at surgical cut margin has a prognostic significance and can be used as a molecular marker for predicting survival in OSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sproll C, Fluegen G, Stoecklein NH (2018) Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer, in Biological Mechanisms of Minimal Residual Disease and Systemic Cancer, J.A. Aguirre-Ghiso, Editor, Springer International Publishing: Cham p 55-82

  2. Padhi S, Saha A, Kar M, Ghosh C, Adhya A, Baisakh M, Mohapatra N, Venkatesan S, Hande MP, Banerjee B (2015) Clinico-pathological correlation of β-catenin and telomere dysfunction in head and neck squamous cell carcinoma patients. J Cancer 6(2):192–202

    Article  Google Scholar 

  3. Liu S-A, Wang CC, Jiang RS, Lee FY, Lin WJ, Lin JC (2017) Pathological features and their prognostic impacts on oral cavity cancer patients among different subsites - a singe institute's experience in Taiwan. Sci Rep 7(1):7451–7451

    Article  Google Scholar 

  4. Al-Swiahb JN et al (2010) Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity. Future Oncol 6(5):837–850

    Article  Google Scholar 

  5. Akhter M, et al. (2011) A study on histological grading of oral squamous cell carcinoma and its correlation with regional metastasis. Vol. 15. 168–76

  6. Viswanatha SC, Hedne N, Hasan S (2019) Correlation between histological grading, LVI and PNI of carcinoma oral tongue to lymph node metastasis. Int J Otorhinolaryngol Head Neck Surg 5(1):2018

    Google Scholar 

  7. Lin YT, Chien CY, Lu CT, Lou SD, Lu H, Huang CC, Fang FM, Li SH, Huang TL, Chuang HC (2015) Triple-positive pathologic findings in oral cavity cancer are related to a dismal prognosis. Laryngoscope 125(9):E300–E305

    Article  Google Scholar 

  8. Jardim JF, Francisco AL, Gondak R, Damascena A, Kowalski LP (2015) Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma. Int J Oral Maxillofac Surg 44(1):23–28

    Article  CAS  Google Scholar 

  9. Chen T-C, et al. (2013) The Impact of Perineural Invasion and/or Lymphovascular Invasion on the Survival of Early-Stage Oral Squamous Cell Carcinoma Patients. Vol. 20

  10. Huh JW, Lee JH, Kim HR, Kim YJ (2013) Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg 206(5):758–763

    Article  Google Scholar 

  11. Al-Sukhni E et al (2017) Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study. Int J Surg 37:42–49

    Article  Google Scholar 

  12. Feuerhahn S, Chen LY, Luke B, Porro A (2015) No DDRama at chromosome ends: TRF2 takes Centre stage. Trends Biochem Sci 40(5):275–285

    Article  CAS  Google Scholar 

  13. Mao Z et al (2007) TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination. Proc Natl Acad Sci U S A 104(32):13068–13073

    Article  CAS  Google Scholar 

  14. Tanaka H, et al. (2005) DNA damage-induced phosphorylation of the human telomere-associated protein TRF2, in Proc Natl Acad Sci U S A. p. 15539–44

  15. Diala I, Wagner N, Magdinier F, Shkreli M, Sirakov M, Bauwens S, Schluth-Bolard C, Simonet T, Renault VM, Ye J, Djerbi A, Pineau P, Choi J, Artandi S, Dejean A, Plateroti M, Gilson E (2013) Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway. EMBO Rep 14(4):356–363

    Article  CAS  Google Scholar 

  16. Saha A, Padhi S, Kar M, Roy S, Maiti P, Banerjee B (2017) Role of TRF2 in efficient DNA repair, spheroid formation and Cancer Stem Cell maintenance. Oncomedicine 2:71–79

    Article  Google Scholar 

  17. Canene-Adams K (2013) Chapter Fifteen - Preparation of Formalin-fixed Paraffin-embedded Tissue for Immunohistochemistry, in Methods in Enzymology, J. Lorsch, Editor, Academic Press. p. 225–233

  18. Ashmead MG (2013) Malignant Neoplasms of the Oral Cavity, in Encyclopedia of Otolaryngology, Head and Neck Surgery, S.E. Kountakis, Editor, Springer Berlin Heidelberg: Berlin, Heidelberg p 1558-1567

  19. Li G et al (2017) Prediction of biomarkers of oral squamous cell carcinoma using microarray technology. Sci Rep 7:42105

    Article  Google Scholar 

  20. Pedro NF et al (2018) Candidate biomarkers for Oral squamous cell carcinoma: differential expression of oxidative stress-related genes. Asian Pac J Cancer Prev 19(5):1343–1349

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Wang R, Yuan Y, Zhou Y, Zhang D, Zhang L, Zeng X, Ji N, Zhou M, Liang X, Chen Y, Geng N, Li J, Chen Q (2018) Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach. Oncol Rep 40(4):2088–2096

    CAS  PubMed  Google Scholar 

  22. Saha A et al (2018) Role of Telomeric TRF2 in Orosphere formation and CSC phenotype maintenance through efficient DNA repair pathway and its correlation with recurrence in OSCC. Stem Cell Rev Rep 14(6):871–887

    Article  Google Scholar 

  23. Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E, Koering CE, Gilson E (2003) Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Clin Cancer Res 9:1105–1111

    CAS  PubMed  Google Scholar 

  24. Miyachi K, Fujita M, Tanaka N, Sasaki K, Sunagawa M (2002) Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res 21:269–275

    CAS  PubMed  Google Scholar 

  25. Pal D, Sharma U, Singh SK, Kakkar N, Prasad R (2015) Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro. PLoS One 10:e0115651

    Article  Google Scholar 

  26. Ozden S, Tiber PM, Ozgen Z, Ozyurt H, Serakinci N, Orun O (2014) Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients. Biol Res 47(1):61

    Article  Google Scholar 

  27. Ning H, Li T, Zhao L, Li T, Li J, Liu J, Liu Z, Fan D (2006) TRF2 promotes multidrug resistance in gastric cancer cells. Cancer Biol Ther 5(8):950–956

    Article  CAS  Google Scholar 

  28. Benhamou Y et al (2016) Telomeric repeat-binding factor 2: A marker for survival and anti-EGFR efficacy in oral carcinoma. Oncotarget 7(28):44236–44251

    Article  Google Scholar 

  29. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

    Article  CAS  Google Scholar 

  30. Mitra A, Mishra L, Li S (2015) EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 6:10697–10711

    Article  Google Scholar 

Download references

Acknowledgements

The authors acknowledge Department of Biotechnology, Government of India for providing grant and technical support of Molecular Stress and Stem Cell Biology (MSSB) group to carry out this study.

Funding

This study was supported by grant from Department of Biotechnology, Government of India, Grant No- BT/PR 17576/MED/30/1690/2016, [Virtual National Oral Cancer Institute (Understanding the Disease Biology and Epigenetic Diversity of Oral Cancer in India: Implications for New Diagnostics and Therapeutics)].

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, 751019, India

    Madhabananda Kar & Mahesh Sultania

  2. Molecular Stress and Stem Cell Biology Group, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Odisha, 751024, India

    Souvick Roy, Swatishree Padhi & Birendranath Banerjee

Authors
  1. Madhabananda Kar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahesh Sultania
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Souvick Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Swatishree Padhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Birendranath Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MK carried out the surgery, planned the experiments, interpreted the clinical data and wrote the manuscript. MS performed the data analysis, interpreted the data and wrote the manuscript. SR and SP collected tissues, processed for experimental analysis, accumulated the data and helped in organizing the manuscript. BNB conceived the idea, guided through the experiments, wrote and edited the manuscript.

Corresponding authors

Correspondence to Madhabananda Kar or Birendranath Banerjee.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kar, M., Sultania, M., Roy, S. et al. TRF2 Overexpression at the Surgical Resection Margin: A Potential Predictive Biomarker in Oral Squamous Cell Carcinoma for Recurrence. Indian J Surg Oncol 12 (Suppl 1), 46–51 (2021). https://doi.org/10.1007/s13193-020-01042-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-020-01042-5

Keywords

Search

Navigation